American Portfolios Advisors Astrazeneca PLC Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, American Portfolios Advisors holds 25,775 shares of AZN stock, worth $2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
25,775
Holding current value
$2 Million
% of portfolio
0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$53.02 - $135.75 $1.37 Million - $3.5 Million
25,775 New
25,775 $1.41 Billion
Q2 2022

Mar 20, 2023
BUY
$59.26 - $71.14 $90,371 - $108,488
1,525 Added 5.92%
27,300 $1.8 Billion
Q1 2022

Mar 21, 2023
BUY
$55.72 - $67.12 $86,867 - $104,640
1,559 Added 6.05%
27,334 $1.81 Billion
Q4 2021

Mar 21, 2023
SELL
$54.02 - $63.83 $171,351 - $202,468
-3,172 Reduced 12.31%
22,603 $1.32 Billion
Q3 2021

Mar 22, 2023
SELL
$55.56 - $60.79 $423,256 - $463,098
-7,618 Reduced 29.56%
18,157 $1.09 Billion
Q2 2021

Mar 22, 2023
SELL
$48.42 - $60.18 $578,764 - $719,331
-11,953 Reduced 46.37%
13,822 $828 Million
Q1 2021

Mar 22, 2023
SELL
$47.16 - $54.44 $590,914 - $682,133
-12,530 Reduced 48.61%
13,245 $659 Million
Q4 2020

Mar 22, 2023
SELL
$48.52 - $58.02 $515,816 - $616,810
-10,631 Reduced 41.25%
15,144 $757 Million
Q3 2020

Mar 22, 2023
SELL
$53.07 - $61.1 $312,104 - $359,329
-5,881 Reduced 22.82%
19,894 $1.09 Billion
Q2 2020

Mar 24, 2023
BUY
$43.1 - $55.31 $349,023 - $447,900
8,098 Added 66.04%
20,360 $1.08 Billion
Q1 2020

Mar 24, 2023
SELL
$37.79 - $51.33 $510,656 - $693,622
-13,513 Reduced 52.43%
12,262 $548 Million
Q4 2019

Mar 24, 2023
SELL
$42.46 - $50.46 $509,562 - $605,570
-12,001 Reduced 46.56%
13,774 $687 Million
Q3 2019

Mar 24, 2023
SELL
$40.12 - $45.47 $31,534 - $35,739
-786 Reduced 5.43%
13,683 $610 Million
Q2 2019

Mar 24, 2023
SELL
$37.28 - $41.68 $421,487 - $471,234
-11,306 Reduced 43.86%
14,469 $597 Million
Q1 2019

Mar 24, 2023
BUY
$35.49 - $43.02 $123,718 - $149,967
3,486 Added 30.97%
14,741 $596 Million
Q4 2018

Mar 24, 2023
SELL
$36.86 - $41.49 $36,417 - $40,992
-988 Reduced 8.07%
11,255 $427 Million
Q3 2018

Mar 24, 2023
SELL
$34.76 - $39.72 $470,372 - $537,491
-13,532 Reduced 52.5%
12,243 $484 Million
Q2 2018

Mar 24, 2023
SELL
$34.55 - $37.05 $3,040 - $3,260
-88 Reduced 0.7%
12,529 $440 Million
Q1 2018

Mar 24, 2023
SELL
$32.97 - $36.63 $433,819 - $481,977
-13,158 Reduced 51.05%
12,617 $441 Million
Q4 2017

Mar 24, 2023
SELL
$32.09 - $34.78 $477,178 - $517,178
-14,870
10,905 $378 Million

Others Institutions Holding AZN

# of Institutions
1,367
Shares Held
512M
Call Options Held
6.08M
Put Options Held
4.44M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $240B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email